(Q48075422)

8 February 2018

title

The burden of disease in rheumatoid arthritis (English)

1 reference

8 February 2018

1 reference

1

Till Uhlig

1 reference

8 February 2018

3

Tore K Kvien

1 reference

8 February 2018

2

Rikke H Moe

1 reference

8 February 2018

publication date

1 September 2014

1 reference

8 February 2018

published in

PharmacoEconomics

1 reference

8 February 2018

volume

32

1 reference

8 February 2018

issue

9

1 reference

8 February 2018

page(s)

841-851

1 reference

8 February 2018

https://scigraph.springernature.com/pub.10.1007/s40273-014-0174-6

exact match

0 references

cites work

Is rheumatoid arthritis disappearing?

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

The prevalence and severity of rheumatoid arthritis in Oslo. Results from a county register and a population survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Prevalence of rheumatoid arthritis in Dublin, Ireland: a population based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Prevalence of rheumatoid arthritis in Italy: the Chiavari Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

The burden of musculoskeletal diseases in the general population of Spain: results from a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed biologics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Low and stable prevalence of rheumatoid arthritis in northern France

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Prevalence of rheumatoid arthritis in France: 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

The prevalence of rheumatic diseases in central Greece: a population survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Prevalence and management of rheumatoid arthritis in the general population of Greece--the ESORDIG study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7-year study from the Oslo RA register

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Which patients with rheumatoid arthritis are still working?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Predictive factors of work disability in rheumatoid arthritis: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Early rheumatoid arthritis 6 years after diagnosis is still associated with high direct costs and increasing loss of productivity: the Swedish TIRA project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Work disability in early rheumatoid arthritis: higher rates but better clinical status in Finland compared with the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Cost-of-illness studies. Useful for health policy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

The burden of rheumatoid arthritis and access to treatment: health burden and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Two-year direct and indirect costs for patients with inflammatory rheumatic joint diseases: data from real-life follow-up of patients in the NOR-DMARD registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

The burden of rheumatoid arthritis and access to treatment: uptake of new therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Validation of the International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis from the patient perspective using focus groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

The burden of illness of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

The mortality of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Why do people with rheumatoid arthritis still die prematurely?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Impact of biologic therapy on functional status in patients with rheumatoid arthritis--a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Malignancy as a comorbidity in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Abdominal discomfort in patients with rheumatoid arthritis is associated with physical and mental function, self-reported disease activity, and use of anti-inflammatory medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Inflammatory arthritis as a novel risk factor for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Initiation and adherence to secondary prevention pharmacotherapy after myocardial infarction in patients with rheumatoid arthritis: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Are young women and men with rheumatoid arthritis at risk for fragility fractures? A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

A comparison of fatigue correlates in rheumatoid arthritis and osteoarthritis: disparity in associations with disability, anxiety and sleep disturbance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Fatigue and factors related to fatigue in rheumatoid arthritis: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

The association of depression and anxiety with medical symptom burden in patients with chronic medical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Comparative quality of life in patients with depression and rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Multimorbidity: prevalence, effect on quality of life and daily functioning, and variation of this effect when one condition is a rheumatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Disease activity and health status in rheumatoid arthritis: a case-control comparison between Norway and Lithuania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Are persons with rheumatoid arthritis deconditioned? A review of physical activity and aerobic capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Physical activity in rheumatoid arthritis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Recommendations and the state of the evidence for physical activity interventions for adults with rheumatoid arthritis: 2007 to present

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Efficacy of cardiorespiratory aerobic exercise in rheumatoid arthritis: meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Disease activity and low physical activity associate with number of hospital admissions and length of hospitalisation in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

A systematic review of the effects of dynamic exercise in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Physical activity maintenance in patients with rheumatoid arthritis: a qualitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Exploring Tai Chi in rheumatoid arthritis: a quantitative and qualitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

A mindfulness-based group intervention to reduce psychological distress and fatigue in patients with inflammatory rheumatic joint diseases: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Treating rheumatoid arthritis to target: recommendations of an international task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Inequities in access to biologic and synthetic DMARDs across 46 European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

The role of biosimilars in the treatment of rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Development of patient-centred standards of care for rheumatoid arthritis in Europe: the eumusc.net project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Development of healthcare quality indicators for rheumatoid arthritis in Europe: the eumusc.net project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Facilitators to implement standards of care for rheumatoid arthritis and osteoarthritis: the EUMUSC.NET project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Health status has improved more in women than in men with rheumatoid arthritis from 1994 to 2009: results from the Oslo rheumatoid arthritis register

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Changes in the rates of joint surgery among patients with rheumatoid arthritis in California, 1983-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Non-drug treatment (excluding surgery) in rheumatoid arthritis: clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Nonpharmacological treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Factors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Dyslipidaemia in Rheumatoid Arthritis: The Role of Inflammation, Drugs, Lifestyle and Genetic Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Are indirect utility measures reliable and responsive in rheumatoid arthritis patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0174-6

Productivity loss at work; health-related and work-related factors

21 January 2018

1 reference

12 December 2020

The Oslo experience with arthritis registries.

1 reference

12 December 2020

Quantification of reduced health-related quality of life in patients with rheumatoid arthritis compared to the general population.

1 reference

12 December 2020

Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic

1 reference

12 December 2020

The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study

1 reference

12 December 2020

Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis

1 reference

12 December 2020

Individualised aerobic and resistance exercise training improves cardiorespiratory fitness and reduces cardiovascular risk in patients with rheumatoid arthritis

1 reference

12 December 2020

Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002-2003.

1 reference

12 December 2020

Lack of exercise is a major cause of chronic diseases

1 reference

12 December 2020

Non-pharmacological interventions for fatigue in rheumatoid arthritis

1 reference

12 December 2020

Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis

1 reference

12 December 2020

The prevalence of rheumatoid arthritis in Sweden

1 reference

12 December 2020

Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country's wealth?

1 reference

12 December 2020

Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study

1 reference

12 December 2020

Incidence and prevalence of rheumatoid arthritis in the county of Troms, northern Norway.

1 reference

12 December 2020

Work limitations among working persons with rheumatoid arthritis: results, reliability, and validity of the work limitations questionnaire in 836 patients

1 reference

12 December 2020

Epidemiology and burden of illness of rheumatoid arthritis

1 reference

12 December 2020

Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register

1 reference

12 December 2020

Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review

1 reference

12 December 2020

Lifestyle- and behaviour-change interventions in musculoskeletal conditions.

1 reference

12 December 2020

Reduction in orthopedic surgery among patients with chronic inflammatory joint disease in Norway, 1994-2004

1 reference

12 December 2020

Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort

1 reference

12 December 2020

The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century

1 reference

12 December 2020

High incidence and prevalence of rheumatoid arthritis in Pima Indians

1 reference

12 December 2020

Prevalence survey of rheumatoid arthritis and spondyloarthropathy in Lithuania

1 reference

12 December 2020

Rheumatoid arthritis and spondyloarthropathies: geographical variations in prevalence in France

1 reference

12 December 2020

The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway.

1 reference

12 December 2020

The prevalence and incidence of work disability in rheumatoid arthritis, and the effect of anti-tumor necrosis factor on work disability

1 reference

12 December 2020

What is the clinical relevance of erosions and joint space narrowing in RA?

1 reference

12 December 2020

Prevalence of rheumatoid arthritis in the South-Transdanubian region of Hungary based on a representative survey of 10,000 inhabitants

1 reference

12 December 2020

10.1007/S40273-014-0174-6

Identifiers

DOI

1 reference

8 February 2018

1 reference

8 February 2018